Loading data for EVGN — first visit, this takes a few seconds.
Evogene Ltd. (EVGN)
NasdaqCM: EVGN
· Real-Time Price · USD
0.51
-0.03 (-5.56%)
At close: Sep 09, 2026, 8:00 PM
0.50
+0.00%
After-hours: 4:10 PM
The price, the headline numbers and the latest news, in one place.
Evogene Ltd. (EVGN) Stock Price, Analysis & Data
No data available
| Bid | 0.37 |
| Market Cap | 7.93M |
| Revenue (ttm) | 1.66M |
| Net Income (ttm) | -17.8M |
| 0.70 | |
| -1.75 | |
| n/a | |
| -0.63 | |
| P/B (ttm) | -2.07 |
| P/S (ttm) | 4.79 |
| Earnings Date | Nov 19, 2026 |
| Ask | 0.68 |
| Volume | 156,700 |
| Avg. Volume (20D) | 1,475,975 |
| Open | 0.53 |
| Previous Close | 0.54 |
| Day's Range | 0.50 - 0.55 |
| 52-Week Range | 0.37 - 1.50 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About EVGN
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engin...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 15, 2010
Employees 38
Stock Exchange NasdaqCM
Ticker Symbol EVGN
Website https://www.evogene.com
Financial Performance
In 2025, Evogene's revenue was 3.85M, a decrease of -30.91% compared to the previous year's 5.58M. Earnings were -8.49M, a decrease of -48.53%.
Financial StatementsEarnings Surprise
Evogene has released their quarterly earnings on Aug 18, 2026:
- Revenue of $334K misses estimates by $0, with -85.74% YoY decline.
- EPS of -0.13 exceeds estimates by 0.14, with 74.00% YoY growth.
Evogene Ltd. is scheduled to release its earnings on Nov 19, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2